PrEP - pre-exposure prophylaxis
Oct 29, 2018 | In the Media, News
There are no easy solutions these days. But often the way through the most difficult moments or problems is via an acknowledgment of human reality: the things we know about ourselves and our communities that we forget when we put on our professional hats, or feel we...
Oct 26, 2018 | In the Media, News
Approximately 148 sexually active emaSwati are needed for an HIV randomised controlled trial investigation that was commissioned by the Ministry of Health Principal Secretary, Dr Simon Zwane, at the Sibane Hotel. “The expectation is that participants will...
Oct 26, 2018 | In the Media, News
ICAP [Country] Director Dr Ruben Sahabo says HPTN study is an opportunity for Eswatini to contribute to the global policy on Pre-Exposure Prophylaxis (PrEP), a core strategy for HIV epidemic control. “The HPTN highlights the country’s commitment to HIV...
Oct 25, 2018 | News
Representatives from the Eswatini Ministry of Health on October 25, 2018, officially launched a groundbreaking study of a new, long-acting, injectable drug for the prevention of HIV infection. This is the first investigational drug trial testing a new form of...
Aug 12, 2018 | In the Media, News
Government will soon roll out the Pre-Exposure-Prophylaxis (PrEP) pill to HIV negative Emaswati following the success of a recent study. This follows the resounding success of the trial of PrEP among thousands of Emaswati who were engaged in the programme since August...